The activation of the aforementioned non-canonical TGF-β-mediated signaling cascades have been implicated in the pathogenesis of fibrosis and fibrotic diseases including renal fibrosis, liver fibrosis, systemic sclerosis and osteoarthritis (107, 108). Here, TGFB1 is linked to systemic sclerosis.